Protective potential of Averrhoa bilimbi fruits in ameliorating the hepatic key enzymes in streptozotocin-induced diabetic rats

Biomedicine and Pharmacotherapy

Volumn 85, Issue , 2017, Pages 725-732

  Kurup, Surya B ^a   S, Mini ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Averrhoa bilimbi Linn; Carbohydrate metabolism; Diabetes mellitus; GC MS analysis; Phytomedicine

Indexed keywords

ACETIC ACID ETHYL ESTER; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; AVERRHOA BILIMBI EXTRACT; FRUCTOSE BISPHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HEXOKINASE; INSULIN; LIVER PROTECTIVE AGENT; METFORMIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PYRUVATE KINASE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; AVERRHOA; AVERRHOA BILIMBI; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; FRUIT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOLYSIS; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; LIVER; LIVER HISTOLOGY; LIVER PROTECTION; LIVER TOXICITY; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; SOLVENT EXTRACTION; SPRAGUE DAWLEY RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WEIGHT CHANGE; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY;

ANIMALS; AVERRHOA; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; ORGAN SIZE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85007420715     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.11.088     Document Type: Article

References (54)

1. [1] Akkati, S., Sam, K.G., Tungha, G., Emergence of promising the rapies in Diabetes mellitus. J. Clin. Pharmacol. 51 (2011), 796–804.
2. [2] International Diabetes Federation, One adult in ten will have diabetes by 2030 Brussels: International Diabetes Federation; http://www.idf.org/media-events/press- releases/2011/diabetes-atlas-5th-edition, 2014.
3. [3] Pari, Leelavinothan, Srinivasan, Subramani, Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed. Pharmacother. 64 (2010), 477–481.
4. [4] Sundaram, R., Naresha, R., Shanthi, P., Sachdanandam, P., Modulatory effect of green tea extract on hepatic key enzymes of glucose metabolism in streptozotocin and high fat diet induced diabetic rats. Phytomedicine 20 (2013), 577–584.
5. [5] Sivakumar, S., Subramanian, S.P., D-pinitol attenuates the impaired activities of hepatic key enzymes in carbohydrate metabolism of streptozotocin-induced diabetic rats. Gen. Physiol. Biophys. 28 (2009), 233–241.
6. [6] Park, K.B., Lee, M., Kim, Y.H., Han, T., Yi, W., Lee, D.H., et al. Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus. Bioorg. Med. Chem. Lett. 23 (2013), 537–542.
7. [7] Kasetti, R.B., Nabi, S.A., Swapna, S., Apparao, C., Cinnamicacid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifolium. Food Chem. Toxicol. 50 (2012), 1425–1431.
8. [8] Goh, S.H., Chuah, C.H., Mok, J.S.L., Soepadmo, E., Malaysian Medicinal Plants for the Treatment of Cardiovascular Diseases, vol. 63, 1995, Pelanduk, Malaysia.
9. [9] Mackeen, M.M., Ali, A.M., El Sharkawy, S.H., Manap, M.Y., Salleh, K.M., Lajis, N.H., et al. Antimicrobial and cytotoxic properties of some Malaysian traditional vegetables (ulam). Int. J. Pharmacogn. 35:3 (1997), 174–178.
10. [10] Ong, H.C.U., Nordiana, M., Malay ethno-medico botany in machang kelantan, Malaysia. Fitoterapia 70 (1999), 502–513.
11. [11] Alsarhan, A.N., Sultana, N., Kadir, M.R.A., Aburjai, T., Ethno pharmacological survey of medicinal plants in Malaysia, the KangkarPulai region. Int. J. Pharmacol. 8:8 (2012), 679–686.
12. [12] Tan, B.K., Fu, P., Chow, P.W., Hsu, A., Effects of A. bilimbi on blood sugar and food intake in streptozotocin-induced diabetic rats. Phytomedicine, 3, 1996, 271.
13. [13] Pushparaj, P., Tan, C.H., Tan, B.K., Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J. Ethnopharmacol. 72 (2000), 69–76.
14. [14] Pushparaj, P.N., Tan, B.K., Tan, C.H., The mechanism of hypoglycemic action of the semi-purified fractions of Averrhoa bilimbi in streptozotocin-diabetic rats. Life Sci. 70 (2001), 535–547.
15. [15] Surya, B. Kurup, Mini, S., Attenuation of hyperglycemia and oxidative stress in streptozotocin induced diabetic rats by aqueous extract of Averrhoa bilimbi Linn fruits. Int. J. Pharm. Sci. Res. 5:11 (2014), 4979–4986.
16. [16] Surya, B. Kurup, Mini, S., Averrhoa bilimbi fruits attenuate hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats. J. Food Drug Anal., 2016, 1–9.
17. [17] Ramesh, B., Pugalendi, K.V., Anti-hyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J. Med. Food 9 (2006), 562–566.
18. [18] Crane, R.K., Sols, A., The association of hexokinase with particulate fractions of brain and other tissue homogenates. J. Biol. Chem. 203 (1953), 273–292.
19. [19] Bucher, T., Pfleiderer, G., Pyruvate kinase from muscle. Methods Enzymol. 1 (1955), 435–440.
20. [20] Koide, H., Oda, T., Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin. Chim. Acta 4 (1959), 554–561.
21. [21] Pontremoli, S., Fructose-1, 6-diphosphatase: I. rabbit liver (crystalline). Methods Enzymol. 9 (1966), 625–631.
22. [22] Disbrey, B.D., Rack, J.H., Book of Histological Laboratory Methods. 1970, Harcourt Brace/ChurchillLivingstone, London.
23. [23] Ivorra, M.D., Paya, M., Villar, A., A review of natural products and plants as potential antidiabetic drugs. J. Ethnopharmacol. 27 (1989), 243–275.
24. [24] Irudayaraj, S.S., Sunil, C., Duraipandiyan, V., Ignacimuthu, S., Antidiabetic and antioxidant activities of Toddalia asiatica (L.) Lam. leaves in streptozotocin induced diabetic rats. J. Ethnopharmacol. 143 (2012), 515–523.
25. [25] Nisha, P., Mini, S., Flavanoid rich ethyl acetate fraction of Musa paradisiacal inflorescence down-regulates the streptozotocin induced oxidative stress, hyperglycaemia and mRNA levels of selected inflammatory genes in rats. J. Funct. Foods 5 (2013), 1838–1847.
26. [26] Pupim, L.B., Heim Burger, Q., Qureshi, A.R., Ikizler, T.A., Stenvinken, P., Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 68 (2005), 2368–2374.
27. [27] Chen, V., Ianuzzo, C.D., Metabolic alterations in skeletal muscle of chronically streptozotocin diabetic rats. Arch. Biochem. Biophy. 217 (1982), 131–138.
28. [28] El-sayed, M. El-sayed, Abo-salem, Osama M., Aly, Hamby A., Mansour, Ahmed M., Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin induced diabetic rats. Pak. J. Pharm. Sci. 2:2 (2009), 168–174.
29. [29] Huckim, Z.S., Patel, B., Goyal, R.K., Effect of chronic Rampiril treatment in STZ induced diabetic rats. Indian J. Physiol. Pharmacol. 41 (1997), 353–360.
30. [30] Kamalakkannan, N., Prince, P.S., Antihyperglycemic and antioxidant effect of Rutin: a Polyphnolic flavonoid in streptozotocin induced diabetic Wistar rats. Basic Clin. Pharmacol. Toxicol. 98 (2006), 97–103.
31. [31] Lekshmi, R.K., Sreekutty, M.S., Mini, S., The regulatory effects of Cissus quadrangularis on some enzymes involved in carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm. Biol. 53 (2015), 1194–1200.
32. [32] Eidi, A., Eidi, M., Esmaeili, E., Antidiabetic effect of garlic (Allium sativum) in normal and streptozotocin-induced diabetic rats. Phytomedicine 13 (2006), 624–629.
33. [33] Eliza, J., Daisy, P., Ignacimuthu, S., Duraipandiyan, V., Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats. Chem. Biol. Interact. 182 (2009), 67–72.
34. [34] DaSilva, D., Ausina, P., Alencar, E.M., Coelho, W.S., Zancan, P., SolaPenna, M., Metformin reverses hexokinase and phosphofructokinase down regulation and intracellular distribution in the heart of diabetic mice. IUBMB Life. 64 (2012), 766–774.
35. [35] Sharma, B., Salunke, R., Balomajumder, C., Daniel, S., Roy, P., Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J. Ethnopharmacol. 127 (2010), 457–462.
36. [36] Waskova-Arnostova, P., Elsnicova, B., Kasparova, D., Sebesta, O., Novotny, J., Neckar, J., et al. Right-to-left ventricular differences in the expression of mitochondrial hexokinase and phosphorylation of Akt. Cell. Physiol. Biochem. 31 (2013), 66–79.
37. [37] Burcelin, R., Printz, R.L., Kande, J., Assan, R., Granner, D.K., Girard, J., Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am. J. Physiol. 265 (1993), 392–401.
38. [38] Gupta, D., Raju, J., Prakash, J., Baquer, N.Z., Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Res. Clin. Pract. 46 (1999), 1–7.
39. [39] Jeoung, N.H., Harris, R.A., Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J. 34 (2010), 274–283.
40. [40] Srinivasan, S., Muruganathan, U., Antidiabetic efficacy of citronellol, a citrus monoterpene by ameliorating the hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 250 (2016), 38–46.
41. [41] Berg, A.H., Combs, T.P., Du, X., Brownlee, M., Scherer, P.E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7 (2001), 947–952.
42. [42] Roden, M., Bernroider, E., Hepatic glucose metabolism in humans-its role in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 17 (2003), 365–383.
43. [43] Pilkis, S.J., Claus, T.H., Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu. Rev. Nutr. 11 (1991), 465–515.
44. [44] Hassan, Sherien Kamal, El-Sammad, Nermin Mohammed, Mousa, Amria Mamdouh, Mohammed, Maha Hashim, el Razik Hussein Farrag, Abd, Eldin Hashim, Amani Nassir, et al. Hypoglycemic and antioxidant activities of Caesalpinia ferrea Martius leaf extract in streptozotocin-induced diabetic rats. Asian Pac. J. Trop. Biomed. 5:6 (2015), 462–471.
45. [45] Leng, S.H., Lu, F.E., Xu, L.J., Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharma-col. Sinica 25 (2004), 496–502.
46. [46] Higdon Jane, R.N., The Bioavailability of Different Forms of Vitamin C. 2001.
47. [47] Shimpo, K., Takahashi, H., Tsuda, H., Hibino, T., Kawai, K., Kimura, C., et al. Inhibition of hepatocellular carcinoma development and erythrocyte polyamine levels in ODS rats fed on 3'-methyl-4-dimethylaminoazobenzene by hemicalcium ascorbate, 2-O-octadecylascorbic acid, and ascorbyl palmitate. Cancer Detect. Prev. 20:2 (1996), 137–145.
48. [48] Farfari, S., Schulz, V., Corkey, B., Prentki, M., Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 49:5 (2000), 718–726.
49. [49] Singab, A.N., El-Beshbishy, H.A., Yonekawa, M., Nomura, T., Fukai, T., Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 100 (2005), 333–338.
50. [50] Rainer Haeckel, Michael Oellerich, Ruth Heerdt, Mannheim-Feudenheim, Manfred Hiibner, Ludwigshafen am Rhein etc inventors; Boehringer Mannheim GmbH, Mannheim, Germany assignee. Hypoglycaemically active 2-(phenylalkyl- or −alkenyl hydrazono)-propionic acid derivatives. US patent 4, 136, 196. 1979 Jan 23.
51. [51] Adnitt, P.I., Hypoglycemic action of monoamino oxidase inhibitors. Diabetes 17 (1968), 628–633.
52. [52] Wickstrom, I., Pettersen, K., Treatment of diabetes with monoamino oxidase inhibitors. Lancet 2 (1964), 995–997.
53. [53] Chester Chenguang Yuan, Nianhe Han, Qingyian Liu, Dustin McMinn, Jay Powers, inventors; Amgen Inc, assignee. N-Cyclo hexyl Benzamides and Benzeneacetamides as inhibitors of 11-Beta-Hydroxysteroid dehydrogenases. US patent 7, 932, 421 B2. 2011 April 26.
54. [54] Kotelevtsev, Yuri, Burchell, Ann, Houston, Pamela M., Schmoll, Dieter, Jamieson, Pauline, et al. 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 14924–14929.